This fast track antibody is not yet fully characterized. It is subject to these terms and conditions

Publishing research using ab43152? Please let us know so that we can cite the reference in this datasheet.

ab43152 has been referenced in 2 publications.

  • Ying M  et al. Bortezomib sensitizes human acute myeloid leukemia cells to all-trans-retinoic acid-induced differentiation by modifying the RARa/STAT1 axis. Mol Cancer Ther 12:195-206 (2013). WB ; Human . PubMed: 23243061
  • Guo Y  et al. Blockade of the Ubiquitin Protease UBP43 Destabilizes Transcription Factor PML/RAR{alpha} and Inhibits the Growth of Acute Promyelocytic Leukemia. Cancer Res 70:9875-85 (2010). WB ; Human . PubMed: 20935222

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"